VRDN - Viridian Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VRDN is currently covered by 11 analysts with an average price target of $37.55. This is a potential upside of $17.47 (87%) from yesterday's end of day stock price of $20.08.

Viridian Therapeutics's activity chart (see below) currently has 21 price targets and 82 ratings on display. The stock rating distribution of VRDN is 96.92% BUY and 3.08% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 13.48% with an average time for these price targets to be met of 124.31 days.

Highest price target for VRDN is $47, Lowest price target is $20, average price target is $37.55.

Most recent stock forecast was given by SERGE BELANGER from NEEDHAM on 07-Jan-2025. First documented stock forecast 20-Jan-2021.

Currently out of the existing stock ratings of VRDN, 63 are a BUY (96.92%), 2 are a HOLD (3.08%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$38

$19.55 (105.96%)

$38

23 days ago
(07-Jan-2025)

0/14 (0%)

$17.04 (81.30%)

Buy

$27

$8.55 (46.34%)

$51

1 months 11 days ago
(19-Dec-2024)

0/4 (0%)

$8.61 (46.82%)

Buy

$34

$15.55 (84.28%)

$34

1 months 13 days ago
(17-Dec-2024)

1/15 (6.67%)

$13.41 (65.13%)

40

Buy

$47

$28.55 (154.74%)

$44

1 months 13 days ago
(17-Dec-2024)

0/11 (0%)

$26.41 (128.27%)

Buy

$28

$9.55 (51.76%)

$31

5 months 18 days ago
(12-Aug-2024)

0/6 (0%)

$12.71 (83.13%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VRDN (Viridian Therapeutics) average time for price targets to be met?

On average it took 124.31 days on average for the stock forecasts to be realized with a an average price target met ratio 13.48

Which analyst has the current highest performing score on VRDN (Viridian Therapeutics) with a proven track record?

JASON BUTLER

Which analyst has the most public recommendations on VRDN (Viridian Therapeutics)?

Jason Butler works at JMP and has 5 price targets and 3 ratings on VRDN

Which analyst is the currently most bullish on VRDN (Viridian Therapeutics)?

Maneka Mirchandaney with highest potential upside - $36.55

Which analyst is the currently most reserved on VRDN (Viridian Therapeutics)?

Michael Higgins with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?